Uterocont
The drug is used as a uterotonic agent for therapeutic and prophylactic purposes in cows for postpartum complications (uterine subinvolution, acute and chronic endometritis) and in sows with MMA syndrome (metritis-mastitis-agalactia), as well as for the prevention of retained placenta in animals. Propranolol belongs to the group of non-selective beta-blockers. The mechanism of action of propranolol involves blocking the beta-adrenergic receptors of the myometrium, which promotes the activity of endogenous oxytocin. As a result, the contraction of the smooth muscles of the uterus and mammary gland is enhanced. In addition, propranolol is an antagonist of catecholamines (a group of similar hormones produced by the adrenal medulla), thereby exhibiting an anti-stress effect.
| Active ingredients |
In 1 ml of the drug contains 80 mg of propranolol (in the form of propranolol hydrochloride), excipients. |
| Dosage and administration |
The drug is administered intramuscularly. |
| Withdrawal periods |
Products from animals after using the drug are allowed to be used for food purposes without restrictions. |
| Presentation |
The drug is produced in glass bottles of 100 ml.
|
| Shelf life |
The shelf life of the drug is two years from the date of manufacture, provided that storage and transportation conditions are observed; after first opening the packaging - 28 days at a temperature from 2 °C to 8 °C. |
| Storage conditions |
The drug should be stored and transported in the manufacturer's packaging, in a place protected from light, at a temperature from 2 °C to 25 °C. |